Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Dow
Johnson and Johnson
Harvard Business School

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR DOPTELET


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Doptelet

Trial ID Title Status Sponsor Phase Start Date Summary
NCT04312789 ↗ Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant Recruiting Dova Pharmaceuticals Phase 2 2020-08-10 This phase II trial studies the side effects and how well avatrombopag works for the treatment of thrombocytopenia after donor hematopoietic stem cell transplant. Thrombocytopenia is defined as abnormally low level of platelets in the blood. Avatrombopag is a small molecule thrombopoietin receptor agonist which stimulates thrombopoietin receptor leading to increase production of platelets.
NCT04312789 ↗ Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant Recruiting National Cancer Institute (NCI) Phase 2 2020-08-10 This phase II trial studies the side effects and how well avatrombopag works for the treatment of thrombocytopenia after donor hematopoietic stem cell transplant. Thrombocytopenia is defined as abnormally low level of platelets in the blood. Avatrombopag is a small molecule thrombopoietin receptor agonist which stimulates thrombopoietin receptor leading to increase production of platelets.
NCT04312789 ↗ Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant Recruiting Basem William, MD Phase 2 2020-08-10 This phase II trial studies the side effects and how well avatrombopag works for the treatment of thrombocytopenia after donor hematopoietic stem cell transplant. Thrombocytopenia is defined as abnormally low level of platelets in the blood. Avatrombopag is a small molecule thrombopoietin receptor agonist which stimulates thrombopoietin receptor leading to increase production of platelets.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Doptelet

Condition Name

Condition Name for Doptelet
Intervention Trials
Immune Thrombocytopenia 3
Thrombocytopenia; Drugs 2
Chronic Liver Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Doptelet
Intervention Trials
Thrombocytopenia 6
Purpura, Thrombocytopenic, Idiopathic 3
Blood Platelet Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Doptelet

Trials by Country

Trials by Country for Doptelet
Location Trials
United States 17
Turkey 4
France 2
Poland 2
Germany 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Doptelet
Location Trials
Ohio 2
Pennsylvania 1
North Carolina 1
New Jersey 1
Nevada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Doptelet

Clinical Trial Phase

Clinical Trial Phase for Doptelet
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Doptelet
Clinical Trial Phase Trials
Not yet recruiting 3
Recruiting 3
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Doptelet

Sponsor Name

Sponsor Name for Doptelet
Sponsor Trials
Dova Pharmaceuticals 3
Sobi, Inc. 1
National Cancer Institute (NCI) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Doptelet
Sponsor Trials
Other 5
Industry 4
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Mallinckrodt
Merck
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.